Trade

with

Durect Corp
(NASDAQ: DRRX)
AdChoices
=
1.32
0.00
0.00%
After Hours :
-
-
-

Open

1.37

Previous Close

1.32

Volume (Avg)

82.30k (218.88k)

Day's Range

1.31-1.37

52Wk Range

1.25-2.69

Market Cap.

147.31M

Dividend Rate ( Yield )

-

Beta

1.35

Shares Outstanding

111.60M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 15.33M

    • Net Income

    • -21.45M

    • Market Cap.

    • 147.31M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -111.43

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.35

    • Forward P/E

    • -

    • Price/Sales

    • 7.82

    • Price/Book Value

    • 5.88

    • Price/Cash flow

    • -9.54

      • EBITDA

      • -20.60M

      • Return on Capital %

      • -44.85

      • Return on Equity %

      • -74.30

      • Return on Assets %

      • -44.85

      • Book Value/Share

      • 0.22

      • Shares Outstanding

      • 111.60M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 16.90

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • -

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • -10.77

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 76.28

            • 64.72

            • Pre-Tax Margin

            • -111.43

            • 13.77

            • Net Profit Margin

            • -111.43

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 82.00

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • -72.50

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.79

              • 0.33

              • Current Ratio

              • 7.02

              • 1.52

              • Quick Ratio

              • 6.10

              • 0.87

              • Interest Coverage

              • -61.93

              • 6.77

              • Leverage Ratio

              • 2.13

              • 1.91

              • Book Value/Share

              • 0.22

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -6.96

                • 63.29

                • P/E Ratio 5-Year High

                • -20.04

                • 237.47

                • P/E Ratio 5-Year Low

                • -3.24

                • 19.71

                • Price/Sales Ratio

                • 7.76

                • 3.53

                • Price/Book Value

                • 5.83

                • 3.31

                • Price/Cash Flow Ratio

                • -9.54

                • 21.23

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -74.30

                    (-78.50)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • -44.85

                    (-25.90)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • -42.32

                    (-78.40)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • -

                  • 27.79k

                  • Inventory Turnover

                  • 1.12

                  • 1.80

                  • Asset Turnover

                  • 0.40

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -21.16M
                  Operating Margin
                  -138.08
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -9.54
                  Ownership

                  Institutional Ownership

                  42.66%

                  Top 10 Institutions

                  33.87%

                  Mutual Fund Ownership

                  8.56%

                  Float

                  95.38%

                  5% / Insider Ownership

                  4.63%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard VIF Small Comp Gr

                  •  

                    2,286,150

                  • 0.00

                  • 2.07

                  • Vanguard US Discoveries Fund

                  •  

                    1,590,707

                  • -6.26

                  • 1.44

                  • Vanguard Total Stock Mkt Idx

                  •  

                    1,550,620

                  • 0.00

                  • 1.39

                  • Vanguard Extended Market Index Fund

                  •  

                    1,252,957

                  • 1.77

                  • 1.12

                  • Bruce Fund

                  •  

                    631,746

                  • 0.00

                  • 0.57

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    379,275

                  • 0.00

                  • 0.34

                  • Vanguard Instl Total Stock Market Index

                  •  

                    291,059

                  • 0.00

                  • 0.26

                  • iShares Micro-Cap

                  •  

                    254,382

                  • 0.00

                  • 0.20

                  • DFA U.S. Micro Cap Portfolio

                  •  

                    204,947

                  • -10.14

                  • 0.18

                  • Bridgeway Ultra Small Company Market

                  •  

                    183,600

                  • 0.00

                  • 0.17

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Arnhold & S. Bleichroeder Advisers, LLC

                  •  

                    10,707,142

                  • 0.00%

                  • 9.69

                  • 683 Capital Management LLC

                  •  

                    4,990,000

                  • +19.66%

                  • 4.52

                  • Granahan Investment Management Inc..

                  •  

                    4,763,275

                  • -0.23%

                  • 4.27

                  • Broadfin Capital, LLC

                  •  

                    4,404,495

                  • 0.00%

                  • 3.99

                  • Vanguard Group, Inc.

                  •  

                    3,190,832

                  • +2.92%

                  • 2.89

                  • BlackRock Fund Advisors

                  •  

                    3,167,846

                  • +4.33%

                  • 2.87

                  • Ironwood Investment Management LLC

                  •  

                    2,718,139

                  • -7.42%

                  • 2.44

                  • Bruce & Co Inc

                  •  

                    1,215,973

                  • 0.00%

                  • 1.10

                  • Zesiger Capital Group LLC

                  •  

                    1,053,800

                  • -9.10%

                  • 0.95

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Slow Growth

                  Style

                  Small Growth

                  Durect Corp was incorporated in Delaware in February 1998. The Company is a specialty pharmaceutical company engaged in the development of pharmaceutical products based on its proprietary drug delivery technology platforms. The Compa...moreny’s product pipeline currently consists of seven investigational drug candidates in clinical development, with one program the subject of a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA).The Company has other programs underway in fields outside of pain management, including several efforts underway which seek to improve the administration of biotechnology agents such as proteins and peptides. The Company’s development efforts are focused on the application of its pharmaceutical systems technologies to potential products in a variety of chron...moreic and episodic disease areas including pain, central nervous system (CNS) disorders, cardiovascular disease and other chronic diseases. Its product candidate include Remoxy (Oral controlled release oxycodone); POSIDUR (Controlled release injection of bupivacaine); ELADUR (Transdermal bupivacaine); TRANSDUR-Sufentanil (Transdermal sufentanil); ORADUR-based opioid (hydrocodone); ORADUR-based opioid (hydromorphone); ORADUR-ADHD; ORADUR-based opioid (oxymorphone); and Relday (risperidone). Its pharmaceutical systems enable optimized therapy for a given disease or patient population by controlling the rate and duration of drug administration. The Company has several technology platforms: Bioerodible Injectable Depot Systems, The TRANSDUR Transdermal Delivery System, The ORADUR Sustained Release Gel Cap Technology, and The DURIN Biodegradable Implant Technology. POSIDUR, SABER, CLOUD, TRANSDUR, ORADUR, ELADUR, DURIN, CHRONOGESIC, MICRODUR, ALZET and LACTEL are the trademarks of the Company. The manufacturing and marketing of its pharmaceutical systems and its research and development activities are subject to extensive regulation for safety, efficacy and quality by numerous government authorities in the United States and abroad.lessless

                  Key People

                  James E. Brown,D.V.M.

                  CEO/Co-Founder/Director/President

                  Dr. Felix Theeuwes,PhD

                  Chairman of the Board/Chief Scientific Officer/Co-Founder/Director

                  Matthew J. Hogan

                  CFO/Chief Accounting Officer/Secretary

                  Dr. Su Il Yum

                  Executive VP, Divisional

                  Mr. Jon S. Saxe

                  Director

                  • Durect Corp

                  • 10260 Bubb Road

                  • Cupertino, CA 95014

                  • USA.Map

                  • Phone: +1 408 777-1417

                  • Fax: +1 408 777-3577

                  • durect.com

                  Incorporated

                  1998

                  Employees

                  101

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: